Dietary Intervention in Food Allergy: Microbiome, Epigenomic and Metabolomic Interactions (DIFAMEM)

Resumen del proyecto

Cumulative evidence suggests that food allergy (FA) is associated with a multitude of environmental factors including hygiene habits, antibiotic use, lifestyle changes and in particular, diet. Changes in nutrition can result in dysbiosis of the skin, gut and lung microbiota and generate changes in microbial metabolites produced, which may in turn produce epigenetic modifications. Current evidence supports the view that epigenetic mechanisms are involved in immune regulation and may represent a key-missing piece of the etiological puzzle for FA, at the interface between the environment and the genome. Dietary fibre can change the gut microbiota composition and therefore cause epigenome changes promoting health. Pectin is one type of dietary fibre that can exert immune regulation and mouse studies have shown its potential in preventing and even curing respiratory allergies. DIFAM aims to investigate the effects of FA treatment through intervention with a prebiotic dietary component, pectin, and using peach allergy as a model. This intervention should be safer than allergen immunotherapy. To verify this, DIFAM will (i) identify how different structural types of pectin affect regulatory immune responses, using mouse models, (ii) assess pectin effects on FA patients, and (iii) develop predictive probabilistic multivariate models for the treatment of FA via integrative analysis of epigenomic, microbiomic, metabolomics and immunologic profiles related to immune modulation. These profiles will be compared to those of patients treated with peach sublingual immunotherapy using samples stored at the IBIMA-Biobank. This project will advance our understanding on how the interaction between dietary components and gut microbiota composition leads to epigenetic changes that provoke the immune modulation, and establish new strategies for dietary intervention in FA, with potential applications for other immune-related diseases.

Palabras clave

alergia alimentaria
tratamiento
epigenoma
microbioma
metabolómica
pectina

Convocatoria

Acción Estratégica en Salud (AES)

Periodo de ejecución

01/01/2019 - 31/12/2021

Investigador Principal

TORRES JAEN, MARIA JOSE

Centro beneficiario

FUNDACION PARA LA INVESTIGACION DE MALAGA EN BIOMEDICINA Y SALUD (FIMABIS)

Centro de realización

INSTITUTO DE INVESTIGACION BIOMEDICA DE MALAGA (IBIMA)

Comunidad Autónoma

Andalucía

Provincia

Málaga

Financiación

194,084 €